High potency active pharmaceutical ingredients (HPAPI) market is anticipated to grow at a significant CAGR during the forecast period. High potent active pharmaceutical ingredients (HPAPIs) are pharmacologically active substances. They exhibit biological activity at extremely low concentrations such as a daily therapeutic dose of <10 mg or an occupational exposure limit (OEL) of < 10 µg/m3 at an eight-hour time-weighted average. The major factor driving the demand for high potency active pharmaceutical ingredients (HPAPI) is the increasing prevalence of cancer. These drugs play an important role to treat many diseases such as cancer. Additionally, the increasing focus of pharmaceutical companies on the development of potent compounds will create ample growth opportunities for the market during the forecast period. However, the growth of the market is hampered due to the high cost involved in transporting and managing HPAPIs.
Some major players in the market include Novartis International AG, Pfizer Inc., and Sanofi SA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2020, Sequens Group announced the opening of a production unit in Villeneuve-La-Garenne, France. The unit was based on the product of a high potency active pharmaceutical.
To Request a Sample of our Report on High Potency Active Pharmaceutical Ingredients (HPAPI) Market: https://www.omrglobal.com/request-sample/high-potency-active-pharmaceutical-ingredients-hpapi-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Novartis International AG, Pfizer Inc., and Sanofi SA, among others.
High Potency Active Pharmaceutical Ingredients (HPAPI) Market Report by Segment
By Type
- Branded HPAPI
- Generic HPAPI
By Application
- Oncology
- Glaucoma
- Hormonal Disorder
- Others
A full Report of High Potency Active Pharmaceutical Ingredients (HPAPI) Market is Available @ https://www.omrglobal.com/industry-reports/high-potency-active-pharmaceutical-ingredients-hpapi-market
High Potency Active Pharmaceutical Ingredients (HPAPI) Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
